Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
153.6 USD | +3.38% | +18.58% | -14.85% |
04-23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
04-23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
16.05B | - | |||||
103B | ||||||
95.28B | ||||||
22.15B | - | |||||
21.02B | - | |||||
18.15B |
- Stock Market
- Equities
- BGNE Stock
- Charts BeiGene, Ltd.
- Sector Chart